Physician profile
Robert Felman
NPI 1720045602
$915.02
in general payments reported to CMS, 2019-2025
16 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.68 · 2020: $65.55 · 2021: $214 · 2022: $196 · 2023: $114 · 2024: $123 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $155.31 | 2021-2023 | |
| Janssen Biotech, INC. | $155.22 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $131.10 | 2020-2022 | |
| Fujifilm Healthcare Americas Corporation | $71.39 | 2024 | Fujifilm |
| Celgene Corporation | $64.64 | 2023 | Zeposia |
| Ironwood Pharmaceuticals, INC | $58.47 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.27 | 2019-2023 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $55.63 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.12 | 2021-2023 | Gattex |
| Redhill Biopharma INC. | $28.01 | 2021 | |
| Mauna Kea Technologies, INC. | $27.37 | 2024 | |
| Ferring Pharmaceuticals INC. | $22.99 | 2019 | |
| Gilead Sciences, INC. | $22.18 | 2022 | |
| Aimmune Therapeutics, INC. | $14.33 | 2025 | Zenpep |
| Braintree Laboratories, INC. | $11.78 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Felman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.